Skip to content
ppharmaranks
Menu

Best treatments for overweight

2 products may treat overweight, spanning FDA drug classes such as glp-1 receptor agonist. The current highest-rated option is saxenda. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.

Quick answer: Of the 2 drugs we list for overweight, 1 is available as lower-cost generics, spanning classes such as glp-1 receptor agonist. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for overweight — so confirm the right choice with your prescriber.

Rated against independent regulatory sources·Last updated August 20, 2026·How we rate

Get treated for overweight online

Licensed online providers — consult & get prescribed if eligible.

Advertising disclosure: We may earn a commission, at no extra cost to you. This never affects our ratings. Details

Top-rated picks for overweight: 1. Saxenda · 2. Wegovy

Top-rated treatments for overweight, ranked by pharmaranks score
#DrugRatingPharmacy pays
170/100$39View →
270/100View →

Full ranking · 2 treatments

Frequently asked

What treats overweight?
Our catalog lists 2 products that may treat overweight, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is saxenda.
What is the best-rated treatment for overweight?
By our independent recall-safety rating — not an efficacy measure — saxenda ranks highest among the products we list for overweight. Always consult a professional.
How are these treatments ranked?
By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
What types of drugs treat overweight?
Treatments for overweight span FDA drug classes including glp-1 receptor agonist. Compare every option side by side, ranked by independent rating, above.

Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.